News and Opinions
A Story For Science: Call to Action, or Currency?
Everybody loves a good story. It doesn’t really matter if it’s true or false or somewhere in between. For stories, the truth is found in the telling - in the narrative. When we hear a story, we’re as much captured by the way it’s told, the meaning behind the...
Stem cell clinics in the legal crosshairs
Columnist Mitchell Hiltzik savaged the La Jolla-based StemGenix Medical Center “The stem cell therapies offered by La Jolla clinic aren’t FDA approved, may not work- and cost $15,000” reads the title of his piece on the LA Times. StemGenix is the subject of a federal...
Welcome to the Disquieting Era of Sheefs
Sheef /ʃiːf/ noun acronym. Synthetic Human Entity with Embryo-like Features. “Change is avalanching upon our heads and most people are grotesquely unprepared to cope with it.” Alvin Toffler (1970)- Future Shock Stem cell engineering has leaped forward so fast that...
Mayo Clinic has credibility, prestige to be game changer in regenerative medicine, says keynote speaker Bernard Siegel.
Left to right are Bernard Siegel, J.D., keynote speaker, and Andre Terzic, M.D., Ph.D., medical director, Center for Regenerative Medicine, at the Mayo Clinic Symposium on Regenerative Medicine and Surgery.March 31, 2017 As a large medical practice, Mayo Clinic...
First transplant of reprogrammed stem cells from another person
A Japanese man has been the first human to receive "reprogrammed” stem cells from another person. As I discussed in detail in a recent post, Japan has implemented a national strategy to develop and translate induced pluripotent stem cells technologies. Japanese...
Towards an endless supply of human blood
What are the implications of scientists creating “immortal” cell lines comprised of healthy red blood cells for transplant and research? An article written by CNN producer Michael Nedelman reports that British scientists, led by University of Bristol researcher Jan...
Clinical Trial Results Buoy Hope for Spinal Cord Injury Patients
The Miami Project to Cure Paralysis, at the University of Miami Miller School of Medicine,has announced the publication of its first Food and Drug Administration (FDA) approved Phase I clinical trial involving Schwann cells used to repair the damaged spinal cord. The...
Converging Technologies and Stem Cells: Towards a Bioartificial Kidney
One of the most exciting trends in medicine today is the invention of new technologies and treatments that depend on the convergence of multiple technologies. Some of these fields include wireless computing, microelectronics, nanotechnology, bioengineering, cell...
CIRM’s Translating Center and Pitching Machine Seek to Speed Up Clinical Trials in the US
The California Institute for Regenerative Medicine (CIRM) is launching the CIRM Translating Center (TC), the first center in the world designed specifically to overcome the unique challenge of manufacturing, safety testing, and other activities needed to successfully...
Why we need a path towards cures. An interview with Sandy Barker
Sandy Barker's life changed when her 13 year-old son Christian was diagnosed with a rare and aggressive form of cancer known as Hypo-diploid Acute Lymphoblastic Leukemia. This was the start of a journey through fear, suffering, and hope, culminating in the painful...
Anouncing the 2016 Stem Action Award Honorees
We are honored and excited to present four extraordinary individuals with the 2016 Stem Cell Action Awards: two visionary philanthropists strategically building translational research projects; a path-finding diabetes researcher motivating the biomedical community to...
Stem Cells heal five damaged monkey hearts
Scientists in Japan have used cardiac muscle cells derived from the stem cells of a monkey to heal the damaged hearts of five other monkeys. The recipient monkeys showed improved cardiac contractile function at 4 and 12 weeks after transplantation, and no evidence of...
Japan Moves Towards Rapid Commercialization
Japan has a fully integrated plan to advance and accelerate regenerative medicine products with safety and efficacy. If successful, this will be a boon for humankind. At the same time it represents a challenge to the international community, and especially the United...
Stem Cell Therapy Pioneer Martin McGlynn Joins our Board of Directors
It is our pleasure to announce the appointment of stem cell therapy pioneer Martin McGlynn to the Board of Directors of Regenerative Medicine Foundation. Mr. McGlynn has long been at the forefront of development in the area of regenerative medicine, having served as...
Bernard Siegel to Address the Stem Cell & Regenerative Medicine Global Congress at CHA Bio Complex, South Korea
WASHINGTON, DC--(Marketwired - August 17, 2016) - The Regenerative Medicine Foundation (RMF) announced that Bernard Siegel, executive director of RMF, will provide the opening keynote address titled "Stem Cells and Regenerative Medicine: the Geo-Political and Societal...
World Stem Cell Summit & RegMed Capital Conference Returns to West Palm Beach
WEST PALM BEACH, Fla., March 28, 2016 -- Regenerative Medicine Foundation (RMF) the producer of the annual World Stem Cell Summit & RegMed Capital Conference, announced the event is returning to West Palm Beach at the Palm Beach County Convention Center for its...
Bipartisan REGROW Act Would Advance Regenerative Cell Therapy
Washington, D.C. – The Bipartisan Policy Center issued the following statement by Janet Marchibroda, director of BPC’s health innovation initiative, regarding the bipartisan, bicameral introduction of the Reliable and Effective Growth for Regenerative Health Options...
Kirk, Manchin, Collins Introduce Bill to Speed Development of Regenerative Medicine
REGROW Act Accelerates New Therapies to Help Patients Living with Disease; Stem Cell Therapies Help Alzheimer’s, Parkinson’s, Sickle Cell Patients U.S. Senators Mark Kirk (R-Ill), Joe Manchin (D-W.Va.) and Susan Collins (R-Maine) today introduced The REGROW Act, S....
Join Regenerative Medicine Foundation
Join today and get access to our newsletter and exclusive updates about events
and all things happening with regenerative medicine.
Join Our Mailing List
The Regenerative Medicine Foundation is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.
Copyright © 2024 Regenerative Medicine Foundation, All rights reserved.